Podoplanin: An emerging cancer biomarker and therapeutic target
Harini Krishnan(Stony Brook University), Gary S. Goldberg(Rowan University)
Cited by 194
Related Papers
Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms
|Oncotarget|2015|87
Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration
|PLoS ONE|2012|72
Normal Cells Control the Growth of Neighboring Transformed Cells Independent of Gap Junctional Communication and Src Activity
|Cancer Research|2004|64
Src Induces Podoplanin Expression to Promote Cell Migration
|Journal of Biological Chemistry|2010|61
Src Utilizes Cas to Block Gap Junctional Communication Mediated by Connexin43
|Journal of Biological Chemistry|2007|39